ALC News and Press, Alcon Inc. From 08/31/21

Of your five senses, eye sight ranks up there as most important, and essential. Unfortunately, for some of us, we don’t have the best vision. In fact, some of us deal with what’s known as Aniseikonia, or as noted by Clinical and Experimental Optometry “is a difference i...

A few signs of strength emerged on Wednesday despite a weak session for the overall markets. For instance, select green-energy stocks managed to post notable gains, bouncing back from recent weakness. Ballard Power Systems (NASDAQ:BLDP) and Ceres Power Holdings (OTCPK:CPWHF) were among t...

Image source: The Motley Fool. Alcon inc (NYSE: ALC) Q2 2021 Earnings Call Aug 18, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Alcon inc (ALC) Q2 2021 Earnings Call Transcript

Shares of Alcon Inc. (NYSE:ALC) traded today at $80.54, eclipsing its 52-week high. This new high was reached on above average trading volume as 2.1 million shares traded hands, while the average 30-day volume is approximately 741,000 shares. Alcon Inc. (NYSE:ALC) has potential upside of...

Virpax Pharmaceuticals (NASDAQ:VRPX) +83%. PharmaCyte Biotech (NASDAQ:PMCB) +67%. BrainsWay Ltd BWAY +17% after FDA's Deep TMS system 510k clearance Novo Integrated Sciences (NASDAQ:NVOS) +14% subsidiary, acenzia, signs exclusive licensing agreement with performance inspired nu...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com But hold on just a second. ...

NVDA,CSCO,ALC,BBWI,SQM,YY,SNPS,KEYS,ZTO,SPTN,OTCQB:VRYYF,RRGB,HOOD For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Wednesday's close

Second quarter sales of $2.1 billion, up 75% or 69% constant currency Growth in all Surgical and Vision Care categories First half cash from operations of $542 million and free cash flow of $320 million Raises full year guidance: sales of $8.0 -...

TOTAL30 delivers the only Water Gradient, reusable lens that is clinically shown to feel like nothing, even on day 30 1 The first breakthrough innovation in the $4 billion reusable lens segment in years 2 Commercially available in the U.S. beginning in Septem...

Robust data demonstrates extremely high level of patient satisfaction and increased spectacle independence for PanOptix ® and Vivity™ PCIOLs – underpinning the strength of these market-leading technologies 1-8 ARGOS ® Biometer with Image G...